  |
 |
 |
THE EFFECTS OF ANTENATAL CORTICOSTEROID TREATMENT ON LACTOGENESIS II |
|
 |
 |
 |
Henderson JJ, Hartmann PE, Newnham JP, Simmer K. Effect of Preterm Birth and Antenatal Corticosteroid Treatment on Lactogenesis II in Women. Pediatrics. 2008;121(1):e92-100.
(For non-journal subscribers, an additional fee may apply for full
text articles.) |
|
 |
Antenatal corticosteroids are routinely given to enhance fetal maturation in an anticipated preterm birth. Henderson et al investigated the effect of both antenatal corticosteroids and preterm birth on the timing of lactogenesis II. Fifty women who had received betamethasone treatment and were expressing breast milk for a preterm infant <34 weeks were included in the study. Exclusion criteria included maternal age younger than 18, no intention to breastfeed, likely poor perinatal outcome, and multiple pregnancy of triplets or greater. All women received a single course of 2 intramuscular injections of 11.4 mg of betamethoasone, 24 hours apart (a standard practice).
Women were encouraged to express a minimum of 6 times per day, including once overnight, by using a commercial electric pump. Digital scales accurate to 0.1g were used to weigh the milk. The primary end points were 24-hour expressed milk on days 1 to 10 postpartum, and levels of lactose and citrate in the milk. Independent variables were gestational age at delivery and time interval between antenatal betamethasone treatment and delivery. Mothers were divided into 2 groups based on the gestational age of their infants: <28 weeks (n=13) and 28–33 weeks (n=37). The median gestational age at delivery was 31 weeks (24.2 to 33.7 weeks) and the median birth weight was 1465g (640g to 2580g). Seventy percent of the infants were male. More than 56% of participants intended to breastfeed for over 6 months and 40% were primiparous.
The investigators found overall milk volume increased from day 1 to day 7 postpartum, with daily milk production rising to a median of 323 ml on day 5 and 530 ml by day 10. Volumes also increased significantly with advancing gestational age at delivery (p=.017), and were significantly associated with frequency of expression (p<.001). There was no effect of gestational age on frequency of expressing (p=.650). The mother’s intended duration of breastfeeding was significantly associated with 24 hour milk volume (p=.002), also unrelated to gestational age. There was no relationship between intended duration of breastfeeding and frequency of expressing (p=780). Expressed milk volume was not associated with any other maternal, antenatal, intrapartum, or neonatal factor, including maternal age, smoking, parity, obstetric complication, cesarean section delivery, or birth weight.
When delivery occurred before 28 week’s gestation, there was no difference in milk volume at the different intervals between betamethasone treatment and delivery. In contrast, when delivery occurred at more advanced gestational ages (between 28 and 33 weeks), there were differences found between the treatment interval groups. Women who delivered 3 to 9 days after treatment obtained significantly reduced volumes of milk compared with the women who delivered 0 to 2 days after treatment. Regarding lactose and citrate levels in the milk, after adjustment for postpartum day, the interval between antenatal betamethasone treatment and delivery was not associated with either milk lactose (p=.857) or citrate (p=.312) levels. Based on this study, lactose and citrate levels are not markers of lactogenesis II in determining the association with antenatal corticosteroid treatment.
This study is the first to investigate the relationship between preterm birth, betamethasone administration, and lactogenesis II. Based on these findings, the NICU staff can advise the mother of the potential benefit of increased pumping frequency to reduce risk of delayed lactogenesis II. Alternatively, explaining the possible physiologic reasons for initial decreased milk production may lessen the anxiety and encourage continued pumping to establish an increased volume of milk production. Such counseling would be most effective for mothers of infants 28 to 33 weeks gestation delivered 3 to 9 days after antenatal corticosteroid treatment. Further, the NICU staff may find it helpful to know the median milk production as identified in this study as a basis for evaluating the preterm mother’s milk production. Finally, these data do support previous findings that frequency of expression strongly predicts both the volume of milk production and concentration of lactose and citrate in milk, so the NICU staff can with confidence continue to encourage regular pumping as an effective strategy for breastfeeding success. |
|
 |
|
 |
|